Higher Rates of Diabetic Ketoacidosis and Admission to the Paediatric Intensive Care Unit Among Newly Diagnosed Children with Type 1 Diabetes in Kuwait During the COVID-19 Pandemic
Overview
Authors
Affiliations
Introduction: The COVID-19 pandemic might have a multifaceted effect on children with type 1 diabetes (T1D), either directly through infection itself or indirectly due to measures implemented by health authorities to control the pandemic.
Objective: To compare data on children newly diagnosed with T1D in Kuwait during the COVID-19 pandemic to the pre-pandemic period.
Research Design And Methods: We analysed data on children aged 12 years or less registered in the Childhood-Onset Diabetes electronic Registry (CODeR) in Kuwait. Data were incidence rate (IR), diabetic ketoacidosis (DKA), and its severity and admission to the paediatric intensive care unit (PICU).
Results: The IR of T1D was 40.2 per 100,000 (95% CI; 36.0-44.8) during the COVID-19 pandemic period and was not statistically different from pre-pandemic. A higher proportion of incident T1D cases presented with DKA and were admitted to the PICU during the pandemic (52.2% vs. 37.8%: p ˂ 0.001, 19.8% vs. 10.9%; p = 0.002, respectively). The COVID-19 pandemic was positively associated with presentation of DKA and admission to PICU (AOR = 1.73; 95% CI, 1.13-2.65; p = 0.012, AOR = 2.04; 95% CI, 1.13-3.67; p = 0.018, respectively). Children of families with a positive history for diabetes were less likely to present with DKA and get admitted to the PICU during the COVID-19 pandemic (AOR = 0.38; 95% CI, 0.20-0.74; p = 0.004, AOR = 0.22; 95% CI, 0.08-0.61; p = 0.004, respectively).
Conclusion: High rates of DKA at presentation and admission to PICU in incident T1D cases during the COVID-19 pandemic warrant further studies and effective mitigation efforts through increasing awareness, early detection, and timely intervention.
Perak E, Mrcela D, Markic J Medicina (Kaunas). 2024; 60(11).
PMID: 39596960 PMC: 11596239. DOI: 10.3390/medicina60111775.
Meregildo-Rodriguez E, Leon-Jimenez F, Tafur-Hoyos B, Vasquez-Tirado G F1000Res. 2024; 12:72.
PMID: 39262444 PMC: 11387936. DOI: 10.12688/f1000research.128687.2.
Al-Abdulrazzaq D, Qabazard M, Al-Jasser F, Al-Anizi A, Al-Basari I, Mandani F Med Princ Pract. 2024; 33(6):555-561.
PMID: 39097968 PMC: 11631037. DOI: 10.1159/000540705.
Endocrinological Involvement in Children and Adolescents Affected by COVID-19: A Narrative Review.
Calcaterra V, Tagi V, De Santis R, Biuso A, Taranto S, DAuria E J Clin Med. 2023; 12(16).
PMID: 37629291 PMC: 10455095. DOI: 10.3390/jcm12165248.
SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus.
Karavanaki K, Karanasios S, Soldatou A, Tsolia M Endocrine. 2023; 82(2):226-236.
PMID: 37587391 PMC: 10543146. DOI: 10.1007/s12020-023-03471-y.